http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102199133-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate | 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102199133-B |
| titleOfInvention | 2 ', 2-double thiazole non-nucleosides compound and preparation method thereof, pharmaceutical composition and the purposes as hepatitis virus inhibitor |
| abstract | The invention belongs to medicinal chemistry art, relate to 2 ' shown in the following general formula I of a class, 2-double thiazole non-nucleosides compound and preparation method thereof, and comprise the pharmaceutical composition of this compounds, this compounds has the activity of anti-hepatitis B virus and anti-hepatitis c virus simultaneously, can be used for treatment hepatitis B and hepatitis C, and this compounds of pharmacokinetics test display has good bioavailability. |
| priorityDate | 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.